Physiological and pathological roles for microRNAs in the immune system - PubMed (original) (raw)
Review
doi: 10.1038/nri2708.
Affiliations
- PMID: 20098459
- DOI: 10.1038/nri2708
Review
Physiological and pathological roles for microRNAs in the immune system
Ryan M O'Connell et al. Nat Rev Immunol. 2010 Feb.
Abstract
Mammalian microRNAs (miRNAs) have recently been identified as important regulators of gene expression, and they function by repressing specific target genes at the post-transcriptional level. Now, studies of miRNAs are resolving some unsolved issues in immunology. Recent studies have shown that miRNAs have unique expression profiles in cells of the innate and adaptive immune systems and have pivotal roles in the regulation of both cell development and function. Furthermore, when miRNAs are aberrantly expressed they can contribute to pathological conditions involving the immune system, such as cancer and autoimmunity; they have also been shown to be useful as diagnostic and prognostic indicators of disease type and severity. This Review discusses recent advances in our understanding of both the intended functions of miRNAs in managing immune cell biology and their pathological roles when their expression is dysregulated.
Similar articles
- microRNAs as potential regulators of myeloid-derived suppressor cell expansion.
El Gazzar M. El Gazzar M. Innate Immun. 2014 Apr;20(3):227-38. doi: 10.1177/1753425913489850. Epub 2013 Jun 11. Innate Immun. 2014. PMID: 23757323 Free PMC article. Review. - MicroRNAs: novel regulators of immunity.
Carissimi C, Fulci V, Macino G. Carissimi C, et al. Autoimmun Rev. 2009 May;8(6):520-4. doi: 10.1016/j.autrev.2009.01.008. Epub 2009 Feb 4. Autoimmun Rev. 2009. PMID: 19200459 Review. - MicroRNAs Reprogram Tumor Immune Response.
Cao W, Cheng W, Wu W. Cao W, et al. Methods Mol Biol. 2018;1699:67-74. doi: 10.1007/978-1-4939-7435-1_4. Methods Mol Biol. 2018. PMID: 29086368 - MicroRNAs and their emerging roles in immunology.
Pauley KM, Chan EK. Pauley KM, et al. Ann N Y Acad Sci. 2008 Nov;1143:226-39. doi: 10.1196/annals.1443.009. Ann N Y Acad Sci. 2008. PMID: 19076353 Review. - MicroRNAs as regulatory elements in immune system logic.
Mehta A, Baltimore D. Mehta A, et al. Nat Rev Immunol. 2016 Apr 28;16(5):279-94. doi: 10.1038/nri.2016.40. Nat Rev Immunol. 2016. PMID: 27121651 Review.
Cited by
- Bibliometric analysis of microRNAs and Parkinson's disease from 2014 to 2023.
Chen L, Chen J, Weng W, Wu M, Zhou X, Yan P. Chen L, et al. Front Neurol. 2024 Sep 25;15:1466186. doi: 10.3389/fneur.2024.1466186. eCollection 2024. Front Neurol. 2024. PMID: 39385824 Free PMC article. - MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets.
Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O. Shaheen N, et al. NPJ Parkinsons Dis. 2024 Oct 5;10(1):186. doi: 10.1038/s41531-024-00791-2. NPJ Parkinsons Dis. 2024. PMID: 39369002 Free PMC article. Review. - Immunogenetic Landscape in Pediatric Common Variable Immunodeficiency.
Szczawińska-Popłonyk A, Ciesielska W, Konarczak M, Opanowski J, Orska A, Wróblewska J, Szczepankiewicz A. Szczawińska-Popłonyk A, et al. Int J Mol Sci. 2024 Sep 17;25(18):9999. doi: 10.3390/ijms25189999. Int J Mol Sci. 2024. PMID: 39337487 Free PMC article. Review. - HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis.
Czopik AK, McNamee EN, Vaughn V, Huang X, Bang IH, Clark T, Wang Y, Ruan W, Nguyen T, Masterson JC, Tak E, Frank S, Collins CB, Li H, Rodriguez-Aguayo C, Lopez-Berestein G, Gerich ME, Furuta GT, Yuan X, Sood AK, de Zoeten EF, Eltzschig HK. Czopik AK, et al. Nat Commun. 2024 Sep 14;15(1):8042. doi: 10.1038/s41467-024-52113-y. Nat Commun. 2024. PMID: 39271652 Free PMC article. - MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease.
Ramadan YN, Kamel AM, Medhat MA, Hetta HF. Ramadan YN, et al. Clin Exp Med. 2024 Sep 11;24(1):217. doi: 10.1007/s10238-024-01476-z. Clin Exp Med. 2024. PMID: 39259390 Free PMC article. Review.
References
- Science. 2008 Sep 12;321(5895):1490-2 - PubMed
- J Exp Med. 2008 Sep 1;205(9):1983-91 - PubMed
- J Autoimmun. 2009 May-Jun;32(3-4):189-94 - PubMed
- Cell. 2008 Mar 7;132(5):860-74 - PubMed
- Immunity. 2007 Dec;27(6):847-59 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K08 CA133521/CA/NCI NIH HHS/United States
- 1K08CA133521/CA/NCI NIH HHS/United States
- K08 CA133521-01A1/CA/NCI NIH HHS/United States
- L30 CA116228/CA/NCI NIH HHS/United States
- L30 CA116228-03/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases